Table 1.
Treatment characteristics in 32 cases with locally implanted Gentamicin and/or Vancomycin in a commercially available antibiotic carrier (CERAMENT™)
| Gentamicin | Vancomycin | Combined | |||
|---|---|---|---|---|---|
| Gender (M:F) | 7:4 | 7:7 | 5:2 | ||
| Indication & Procedure | |||||
| Therapeutic (PJI) | 3 | 6 | 3 | ||
| DAIR | 1 | 2 | 2 | ||
| 1-Stage | 2 | 2 | 0 | ||
| 2-Stage | 0 | 2 | 1 | ||
| Prophylactic | 8 | 8 | 4 | ||
| Primary Tumour-prosthesis | 7 | 4 | 3 | ||
| Revision Arthroplasty | 1 | 4 | 1 | ||
| Antibiotic Carrier mean volume (mL) and corresponding antibiotic concentration (mg). |
CERAMENT™|G & CERAMENT™|V | ||||
| 12.1 (3-20) | 11.1 (5-20) | 9.7 (8-10) | 10 (10-10) | ||
| 211,75 (52,5-350) | 732,6 (330-1320) | 169,75 (140-175) | 660 (660-660) | ||